EyeGate Pharmaceuticals Inc (EYEG) - Medical Equipment - Deals and Alliances Profile

Date: July 12, 2017
Pages: 30
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E4124A0F9DAEN
Leaflet:

Download PDF Leaflet

EyeGate Pharmaceuticals Inc (EYEG) - Medical Equipment - Deals and Alliances Profile
Summary

EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical company that offers eye care medicines. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient adherence and patient safety. EyeGate deliver drugs in optimal dosing regimens directly into the ocular tissue in both the anterior and posterior segments of the eye. The company offers EGP-437 that incorporates a reformulated corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues. It also offers drug delivery mechanisms for treating diseases of the eye. EyeGate is headquartered in Waltham, Massachusetts, the US.

EyeGate Pharmaceuticals Inc (EYEG) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deal Details
Venture Financing
EyeGate Pharma Raises USD2.6 Million in Venture Financing
EyeGate Pharma Raises US$1 Million In Venture Financing
EyeGate Pharma Secures An Additional US$5.9 Million In Series D Round Of Financing
Partnerships
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Equity Offering
EyeGate Pharma Raises USD10 Million in Public Offering of Shares and Warrants
EyeGate Pharmaceuticals Inc - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
May 08, 2017: EyeGate Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update
Feb 23, 2017: EyeGate Pharmaceuticals Reports Full-year 2016 Financial Results and Provides Business Update
Nov 02, 2016: EyeGate Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update
Aug 10, 2016: EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update
May 13, 2016: Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update
Mar 29, 2016: EyeGate Reports Full-year 2015 Financial Results and Provides Business Update
Corporate Communications
Feb 06, 2017: EyeGate Pharmaceuticals Announces Executive Promotions
May 06, 2016: EyeGate Pharma Appoints Dr. Brenda K. Mann as Vice President, Research and Development
Apr 27, 2016: EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial Officer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

EyeGate Pharmaceuticals Inc, Medical Equipment, Key Facts, 2016
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
EyeGate Pharma Raises USD2.6 Million in Venture Financing
EyeGate Pharma Raises US$1 Million In Venture Financing
EyeGate Pharma Secures An Additional US$5.9 Million In Series D Round Of Financing
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
EyeGate Pharma Raises USD10 Million in Public Offering of Shares and Warrants
EyeGate Pharmaceuticals Inc, Key Competitors
EyeGate Pharmaceuticals Inc, Key Employees
EyeGate Pharmaceuticals Inc, Subsidiaries

LIST OF FIGURES

EyeGate Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017
Skip to top


Ask Your Question

EyeGate Pharmaceuticals Inc (EYEG) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: